Cocrystal Pharma (COCP) Non Operating Investment Income (2014 - 2015)
Cocrystal Pharma (COCP) reported Non Operating Investment Income of $744000.0 for Q2 2015, down 77.82% on a YoY basis from $3.4 million in Q2 2014, and up 175.92% sequentially from -$980000.0 in Q1 2015.
Cocrystal Pharma (COCP) Non Operating Investment Income (2014 - 2015) Analysis & Trends
Cocrystal Pharma (COCP) has 2 years of Non Operating Investment Income data on file, last reported at $744000.0 in Q2 2015.
- For the quarter ending Q2 2015, Non Operating Investment Income fell 77.82% year-over-year to $744000.0; the trailing twelve-month figure through Jun 2015 stood at -$704000.0 (changed N/A YoY), and the FY2014 full-year result was $1.4 million, changed N/A from the prior year.
- Non Operating Investment Income advanced to $744000.0 in Q2 2015, from -$980000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $3.4 million in Q2 2014 to a low of -$980000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 744,000.00 |
| Jun 30, 2015 | 744,000.00 |
| Mar 31, 2015 | -980,000.00 |
| Mar 31, 2015 | -980,000.00 |
| Dec 31, 2014 | -876,000.00 |
| Dec 31, 2014 | -876,000.00 |
| Sep 30, 2014 | 408,000.00 |
| Sep 30, 2014 | 408,000.00 |
| Jun 30, 2014 | 3.35 Mn |
| Jun 30, 2014 | 3.35 Mn |